James S. Fallon – Trademark Portfolio

Entity Type: 01

James S. Fallon holds 23 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 19 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 15 trademarks are registered. Notable registered marks include BRUXOR, SLEEPRX, BRUXORMD, FLEX JAW, and SNORE MD. The owner is based in Aliso Viejo, CA.

27121 Aliso Creek Road, Building 140

Aliso Viejo, CA 92656

23 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

James S. Fallon's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (19 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does James S. Fallon have?

James S. Fallon has 23 U.S. trademarks filed with the USPTO. Of these, 15 registered, 7 abandoned, 1 cancelled.

What trademark classes does James S. Fallon file in?

James S. Fallon files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are James S. Fallon's most well-known trademarks?

James S. Fallon's registered trademark portfolio includes well-known marks such as BRUXOR, SLEEPRX, BRUXORMD, FLEX JAW, and SNORE MD. These are among 15 currently registered trademarks in the portfolio.

What is James S. Fallon's trademark registration success rate?

James S. Fallon has a 65% trademark registration rate, with 15 out of 23 resolved applications resulting in successful registration. Currently, 0 applications are pending review.